Weekly Journal Scan: improved renal outcomes by semaglutide in patients with chronic kidney disease and type 2 diabetes in FLOW trial

被引:1
|
作者
Pedicino, Daniela [1 ]
Volpe, Massimo [2 ,3 ]
机构
[1] Fdn Policlin Univ A Gemelli IRCCS, Dept Cardiovasc Med, Largo A Gemelli 8, I-00168 Rome, Italy
[2] Sapienza Univ Rome, Dept Clin & Mol Med, Via Grottarossa 1035, Rome, Italy
[3] IRCCS San Raffaele Roma, Via Valcannuta 250, Rome, Italy
关键词
GLP-1 RECEPTOR AGONISTS; MORTALITY;
D O I
10.1093/eurheartj/ehae429
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:3910 / 3911
页数:2
相关论文
共 50 条
  • [31] Prevalence of occult chronic kidney disease and associated variables in a population of patients with type 2 diabetes
    Rodriguez-Poncelas, Antonio
    Quesada Sabate, Miquel
    Coll De Tuero, Gabriel
    Caula Ros, Jacint
    Gelada-Batlle, Esther
    Angel Gomez-Marcos, Manuel
    Garre-Olmo, Josep
    Garcia-Ortiz, Luis
    Comalada Daniel, Carme
    Ramos Blanes, Rafel
    MEDICINA CLINICA, 2010, 134 (06): : 239 - 245
  • [32] Unmet needs and opportunities for optimal management of patients with type 2 diabetes and chronic kidney disease
    Pantalone, Kevin M.
    Ji, Xinge
    Kong, Sheldon X.
    Elliott, Jay C.
    Milinovich, Alex
    Misra-Hebert, Anita D.
    Farej, Ryan
    Singh, Rakesh
    Bauman, Janine M.
    Zimmerman, Robert S.
    Vachharajani, Tushar J.
    Partridge, Jamie
    Cameron, Jennifer
    Williamson, Todd
    Kattan, Michael W.
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2023, 37 (04)
  • [33] Subclinical hypothyroidism and the associations with macrovascular complications and chronic kidney disease in patients with Type 2 diabetes
    Jia, F.
    Tian, J.
    Deng, F.
    Yang, G.
    Long, M.
    Cheng, W.
    Wang, B.
    Wu, J.
    Liu, D.
    DIABETIC MEDICINE, 2015, 32 (08) : 1097 - 1103
  • [34] Prevalence of chronic kidney disease in patients with type 2 diabetes mellitus treated in primary care
    Lou Arnal, L. M.
    Campos Gutierrez, B.
    Cuberes Izquierdo, M.
    Gracia Garcia, O.
    Turon Alcaine, J. M.
    Bielsa Garcia, S.
    Gimeno Orna, J. A.
    Boned Juliani, B.
    Sanjuan Hernandez-French, A.
    NEFROLOGIA, 2010, 30 (05): : 552 - 556
  • [35] Erythropoietic Response and Outcomes in Kidney Disease and Type 2 Diabetes.
    Solomon, Scott D.
    Uno, Hajime
    Lewis, Eldrin F.
    Eckardt, Kai-Uwe
    Lin, Julie
    Burdmann, Emmanuel A.
    de Zeeuw, Dick
    Ivanovich, Peter
    Levey, Andrew S.
    Parfrey, Patrick
    Remuzzi, Giuseppe
    Singh, Ajay K.
    Toto, Robert
    Huang, Fannie
    Rossert, Jerome
    McMurray, John J. V.
    Pfeffer, Marc A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (12) : 1146 - 1155
  • [36] Multimodal efforts to slow the progression of chronic kidney disease in patients with type 2 diabetes mellitus
    Rastogi, Anjay
    Weir, Matthew R.
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2023, 37 (08)
  • [37] Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial
    Gullaksen, Soren
    Vernstrom, Liv
    Sorensen, Steffen S.
    Ringgaard, Steffen
    Laustsen, Christoffer
    Funck, Kristian L.
    Poulsen, Per L.
    Laugesen, Esben
    DIABETOLOGIA, 2023, 66 (05) : 813 - 825
  • [38] Mild to moderate chronic kidney disease and cardiovascular events in patients with type 2 diabetes mellitus
    Lessey, Gayatri
    Stavropoulos, Konstantinos
    Papademetriou, Vasilios
    VASCULAR HEALTH AND RISK MANAGEMENT, 2019, 15 : 365 - 373
  • [39] Risk of chronic kidney disease in patients with a hyperglycemic crisis as the initial presentation of type 2 diabetes
    Huang, Chun-Ta
    Muo, Chih-Hsin
    Sung, Fung-Chang
    Chen, Pei-Chun
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [40] Metformin and the Risk of Anemia of Advanced Chronic Kidney Disease in Patients With Type 2 Diabetes Mellitus
    Wu, Chien-Tung
    Tsai, Yueh-Ting
    Jung, Hsuan-Kuang
    Fu, Shu-Ling
    Hsiung, Chao Agnes
    Liu, Hsiao-Yu
    Lai, Jung-Nien
    JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 62 (02) : 276 - 284